Don't miss out on these discounted products!
Act fast before the sale ends!
The following products are currently out of stock
Don't miss out on these discounted products!
Act fast before the sale ends!
The following products are currently out of stock
This section outlines the evolution and milestones of Behemothlabz from its founding in 2014 to its continued growth and innovation in 2024.
This section provides all our contact details, encouraging you to reach out for assistance or inquiries. It encompasses live chat, phone support, and email options, ensuring accessibility for all.
Discover all you need to know to partner with us and promote our products to earn rewards.
In our FAQs section, we have compiled answers to the questions we frequently receive. Quickly find information about our company, products, and policies. If you have any questions, you might find the answer here before reaching out to us directly.
In our Quality Control and Testing section, we uphold Behemothlabz’s Commitment to Quality by meticulously detailing our procedures.
Sign up Here for our regular newsletter and stay updated.
HGH Fragment 176-191 is a synthetic peptide derived from human growth hormone (HGH). It consists of amino acids 176 to 191 of the HGH protein. This specific fragment is believed to retain some of the lipolytic (fat-reducing) properties of the full-length HGH molecule. It has been studied for its potential to promote fat loss and aid in weight management. Researchers have investigated its effects in various contexts, but it’s important to emphasize that these studies are typically conducted for scientific research purposes, and not for any medical or therapeutic applications.
Packaged in an air-sealed mylar bag. Keep contents sealed and stored in a cool dry place. Items are shipped in a plain envelope or bubble mailer within 24-48 hours (or the next business day).
HGH 176-191, a synthetic analog of human growth hormone, consists of a peptide chain comprising 16 amino acids. It is often colloquially termed the “lipolytic fragment” of HGH, based on research indicating its potential to induce fat loss in animal models [R].
Animal studies have suggested that HGH 176-191 holds promise as an anti-obesity agent. Furthermore, a cell-based investigation has revealed that this modified HGH variant enhances the anti-cancer effectiveness of compounds designed to target breast cancer cells [R].
HGH Fragment 176-191 operates by targeting specific mechanisms. It primarily influences the regulation of fat metabolism and fat breakdown. Here’s a simplified explanation of the proposed mechanism of action:
HGH Fragment 176-191 is believed to stimulate lipolysis, which is the breakdown of fats into fatty acids and glycerol. This process encourages the release of stored body fat, making it available for energy consumption.
This fragment primarily affects fat cells and does not significantly impact other cellular activities. It is designed to be selective in promoting fat loss while avoiding broader systemic effects typically associated with full-length human growth hormone (HGH).
By enhancing the mobilization and utilization of fat for energy, HGH Fragment 176-191 may support weight management and fat loss efforts in subjects.
It’s crucial to emphasize that the use of HGH Fragment 176-191 in research is for scientific purposes and should not be associated with human consumption or medical applications.
Numerous animal and cell-based investigations have been undertaken to explore the properties of HGH Fragment 176-191. Findings from these studies indicate that this synthetic peptide exhibits the potential to trigger lipolysis, inhibit lipogenesis, and augment the cytotoxicity of compounds targeting cancer cells in breast cancer lines.
In mice, HGH Fragment 176-191 has exhibited a transient increase in blood glucose levels, followed by a more prolonged elevation in plasma insulin levels. Furthermore, this research compound has displayed promise in terms of weight management and fat reduction effects.
An animal investigation unveiled compelling findings, demonstrating that a 14-day regimen of HGH Fragment 176-191 brought about a decrease in body weight and body fat among obese mice. The researchers observed that this synthetic peptide facilitated fat loss by elevating energy expenditure and encouraging the oxidation of fat reserves [R].
Animal research highlighted a noteworthy discovery, as daily oral doses of HGH 176-191 effectively curtailed over 50% of the weight gain in the subjects when compared to the control group. This outcome underscores the potential of this synthetic peptide as a safe therapeutic candidate for obesity management [R].
Additionally, in another mouse study, chronic treatment with HGH or its HGH 176-191 counterpart increased the oxidation of fat cells in obese individuals and contributed to weight loss. It’s worth noting that, unlike full-length HGH, this specific fragment did not induce hyperglycemia, reduce insulin secretion, or compete for HGH receptors [R].
A cell-based investigation unveiled a noteworthy finding, indicating that HGH Fragment 176-191 amplified the cytotoxic effectiveness of compounds designed to target breast cancer cells. In particular, chitosan nanoparticles loaded with HGH 176-191 displayed potential for enhanced cytotoxicity against breast cancer cells, offering promise in the field of anti-cancer research [R].
Moreover, the incorporation of HGH 176-191 in nanoparticles may facilitate their accumulation in tumor tissues while minimizing exposure to non-targeted tissues. This holds the potential to enhance the therapeutic efficacy and mitigate adverse effects associated with this anti-cancer compound.
A study conducted in 2016 shed light on the potential benefits of hyaluronic acid loaded with HGH 176-191 in a rabbit model of osteoarthritis. Results demonstrated that this combination was more effective than either hyaluronic acid or HGH Fragment 176-191 alone. Furthermore, intra-articular administration of HGH Fragment 176-191 was found to enhance cartilage regeneration. It was also observed that osteoarthritic rabbits receiving HGH 176-191 injections exhibited reduced morphological and histopathological damage compared to the control group [R].
HGH Fragment 176-191, a synthetic peptide, has shown promise in various research studies. It demonstrated the potential to reduce body weight and fat in obese animals by increasing energy expenditure and fat oxidation. Moreover, it enhanced lipolytic activity without adversely affecting insulin sensitivity. In obesity studies, it significantly curtailed weight gain without inducing hyperglycemia. HGH Fragment 176-191 also exhibited potential in enhancing the cytotoxicity of compounds targeting breast cancer cells. Additionally, in osteoarthritis research, its combination with hyaluronic acid proved more effective in promoting cartilage regeneration and reducing damage, offering therapeutic potential in various contexts.
Behemoth Labz is the best place to buy HGH Fragment 176-191 online.
We have been around since 2014, supplying the highest-quality research chemicals money can buy. All of our products come with a 100% satisfaction guarantee, free and fast shipping, and a money-back guarantee on HGH Fragment 176-191.
Please make sure you go through the Terms and Conditions, and please familiarize yourself with it as it is important. Please research the scientific uses of this product before making any purchases. Make note that the packaging and labels of the product may differ from those shown on the website.
Buying the product means you agree with our Terms and Conditions. You can contact our awesome customer service team at [email protected] if you are not fully satisfied with the product. Customer satisfaction is our number one priority!
ATTENTION: All BehemothLabz products are strictly for LABORATORY AND RESEARCH PURPOSES ONLY. They are not to be used for any human or veterinary purposes.
Strength | 50mcg per spray/5mg/10ml |
---|
Reviews
There are no reviews yet